U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

i

Maresin-1 regulates epithelial to mesenchymal transition and wound healing processes in bronchial epithelial cells



Details

  • Personal Author:
  • Description:
    Rationale: In the airway epithelium, epithelial to mesenchymal transition (EMT) can be a reparative or pathologic process, depending on the activation stimulus and regulatory cues governing the process. Pro-resolving lipid mediators have recently been implicated as both positive and negative regulators of EMT-related pathways. We sought to determine how the pro-resolving lipid mediator maresin-1 (MaR1) regulates the EMT response to pro-inflammatory stimuli in bronchial epithelial cells. Methods: Primary human bronchial epithelial cells or the transformed bronchial epithelial cell line BEAS-2B were stimulated with 5 ng/mL TGF-B1 in the presence or absence of 1 - 100 nM MaR1. Cultures were assessed over 96 hours to ascertain how MaR1 treatment altered TGF-B1-induced EMT. Western blotting and gel zymography were performed to ascertain protein expression and protease activities, and confluent cultures were wounded and wound closure was monitored. Results: TGF-B1-treated cultures exhibited morphological changes of mesenchymal transition by 72 hr following treatment. These changes correlated with loss of E-cadherin expression and increased fibronectin, MMP-2 and MMP-9 release. However, TGF-B1-induced loss of E-cadherin expression was repressed by 1 nM MaR1 treatment, and 100 nM MaR1 reduced TGF-B1 induction of fibronectin production. TGF-B1 increased MMP-2 protein expression and protease activities nearly two-fold, while cultures treated with MaR1 exhibited MMP-2 protease activities similar to controls. Despite inhibiting E-cadherin loss and MMP-2 protease activities, MaR1 did not impair TGF-B1-mediated increased wound healing capacity, and MaR1 treatment alone increased wound healing as compared to untreated, wounded cultures. Conclusions: Our results suggest the pro-resolving lipid mediator MaR1 regulates the bronchial epithelial response to inflammation and wounding, encouraging maintenance of epithelial programing during non-injurious inflammatory insults, and speeding healing following wounding. [Description provided by NIOSH]
  • Subjects:
  • Keywords:
  • ISSN:
    1073-449X
  • Document Type:
  • Funding:
  • Genre:
  • Place as Subject:
  • CIO:
  • Topic:
  • Location:
  • Volume:
    193
  • NIOSHTIC Number:
    nn:20048504
  • Citation:
    Am J Respir Crit Care Med 2016 May; 193(Abstract Issue):A5896
  • Email:
    tnordgren@unmc.edu
  • Federal Fiscal Year:
    2016
  • Performing Organization:
    University of Nebraska Medical Center, Omaha, Nebraska
  • Peer Reviewed:
    False
  • Start Date:
    20060801
  • Source Full Name:
    American Journal of Respiratory and Critical Care Medicine
  • Supplement:
    Abstract Issue
  • End Date:
    20160731
  • Collection(s):
  • Main Document Checksum:
    urn:sha-512:345018ad3b86333d6c71252556185b9f6270823d19a11243c00cf64363d8f9cc1b66422bec6c26a4e52394e04eb39d4dc37851b7167feedeb20e1641c60e86a5
  • Download URL:
  • File Type:
    Filetype[PDF - 16.92 KB ]
ON THIS PAGE

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.